enGene Holdings ENGN 深 沪
已收盘 05-15 16:00:00 美东时间
1.72
-0.090
-4.97%
华盛通- 最 高1.76
- 今 开1.75
- 成交量 275.02万股
- 最 低 1.625
- 昨 收 1.81
- 总市值 1.15亿
- 52周最高 12.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.40
- 委 比 -95.68%
- 总股本 6698.95万
- 历史最高 43.00
- 量 比 0.37
- 振 幅 7.46%
- 历史最低 1.40
- 每 手 1
- 风险率 2.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Why Is enGene Therapeutics Stock Falling Friday?
enGene stock sinks after Phase 2 bladder cancer trial shows durability concerns. Analysts slash price forecasts as the sell-off intensifies.
05-08 23:34
股价暴跌80%！enGene宣布II期临床失败
（来源：药时代） 2026年5月7日，加拿大药企enGene Holdings（NASDAQ: ENGN）遭遇资本巨震，股价暴跌约80%，报1.72美元/股...
05-08 18:41
Piper Sandler Downgrades enGene Therapeutics to Neutral, Lowers Price Target to $4
Piper Sandler analyst Allison Bratzel downgrades enGene Therapeutics (NASDAQ:ENGN) from Overweight to Neutral and lowers the price target from $7 to $4.
05-08 18:01
Dow Dips 350 Points; US Foods Posts Downbeat Earnings
Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US Foods reports lower Q1 earnings and sales. Agilon Health, Aaon, and Rackspace Technology see gains while Entrada, Fastly, and enGene Therapeutics decline. Euro zone and Asian markets mixed.
05-08 01:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Agilon Health (NYSE:AGL) shares moved upwards by 115.7% to $60.08 duri...
05-08 01:05
美股大行评级 | 大摩上调哔哩哔哩目标价从25美元升至31美元；大砍近50%！汇丰下调耐克目标价从90美元降至48美元
今日重点评级关注：HC Wainwright & Co.：维持Solaris Resources"买入"评级，目标价从16美元升至18美元；Leerink Partners：维持Spyre Therapeutics"跑赢大市"评级，目标价从49美元升至106美元
04-14 10:44
enGene Therapeutics Rebrands as Company Nears Commercialization
enGene Holdings ( ($ENGN) ) has provided an update. enGene Therapeutics Inc., a...
04-10 04:38
enGene Holdings To Change Its Corporate Name To enGene Therapeutics Effective April 8
Name change reflects transition towards potential commercial organization in 2027Planned Biologics License Application (BLA) submission for detalimogene in 2H 2026enGene Therapeutics Inc. (formerly, enGene Holdings Inc.)
04-07 20:11
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
